Delivery Order SPE2DB22D3401-SPE2DB24FT3DU
Award Date
5/28/24
Potential Completion Date
6/18/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.75 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to support DLA's medical supply programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with an award ID of SPE2DX15D3004|SPE2DX22FGBP4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,114,056.00 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX15D1021|SPE2DX23FHRHY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,788.93 firm-fixed-price delivery order is for the supply of 4560616947 ! TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $55,702.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to the government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,418.75 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, with a performance period extending through April 12, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at up to $3,700.32, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical products. This is a Firm Fixed Price delivery order contract with an ultimate completion date of September 3, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,140.50 order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of March 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor, delivering this product to support...
This federal contract award is for the delivery of TICOVAC 2.4 MCG/0.5 ML syringes to the Defense Logistics Agency (DLA). The $18,501.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF3XS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $1,856.75 and a completion date of March 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program....
This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a potential value of $3,713.52. The order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug...